Antibacterial medication use during pregnancy and risk of birth defects: National Birth Defects Prevention Study
- PMID: 19884587
- DOI: 10.1001/archpediatrics.2009.188
Antibacterial medication use during pregnancy and risk of birth defects: National Birth Defects Prevention Study
Abstract
Objective: To estimate the association between antibacterial medications and selected birth defects.
Design, setting, and participants: Population-based, multisite, case-control study of women who had pregnancies affected by 1 of more than 30 eligible major birth defects identified via birth defect surveillance programs in 10 states (n = 13 155) and control women randomly selected from the same geographical regions (n = 4941).
Main exposure: Reported maternal use of antibacterials (1 month before pregnancy through the end of the first trimester).
Main outcome measure: Odds ratios (ORs) measuring the association between antibacterial use and selected birth defects adjusted for potential confounders.
Results: The reported use of antibacterials increased during pregnancy, peaking during the third month. Sulfonamides were associated with anencephaly (adjusted OR [AOR] = 3.4; 95% confidence interval [CI], 1.3-8.8), hypoplastic left heart syndrome (AOR = 3.2; 95% CI, 1.3-7.6), coarctation of the aorta (AOR = 2.7; 95% CI, 1.3-5.6), choanal atresia (AOR = 8.0; 95% CI, 2.7-23.5), transverse limb deficiency (AOR = 2.5; 95% CI, 1.0-5.9), and diaphragmatic hernia (AOR = 2.4; 95% CI, 1.1-5.4). Nitrofurantoins were associated with anophthalmia or microphthalmos (AOR = 3.7; 95% CI, 1.1-12.2), hypoplastic left heart syndrome (AOR = 4.2; 95% CI, 1.9-9.1), atrial septal defects (AOR = 1.9; 95% CI, 1.1-3.4), and cleft lip with cleft palate (AOR = 2.1; 95% CI, 1.2-3.9). Other antibacterial agents that showed associations included erythromycins (2 defects), penicillins (1 defect), cephalosporins (1 defect), and quinolones (1 defect).
Conclusions: Reassuringly, penicillins, erythromycins, and cephalosporins, although used commonly by pregnant women, were not associated with many birth defects. Sulfonamides and nitrofurantoins were associated with several birth defects, indicating a need for additional scrutiny.
Comment in
-
Treating UTIs in reproductive-age women-proceed with caution.J Fam Pract. 2010 Apr;59(4):220-2. J Fam Pract. 2010. PMID: 20398580 Free PMC article.
-
Use of nitrofurantoin and sulfa in early pregnancy is associated with birth defects.J Midwifery Womens Health. 2010 Jul-Aug;55(4):391-2. doi: 10.1016/j.jmwh.2010.04.003. J Midwifery Womens Health. 2010. PMID: 20630368 No abstract available.
Similar articles
-
Maternal injuries during the periconceptional period and the risk of birth defects, National Birth Defects Prevention Study, 1997-2005.Paediatr Perinat Epidemiol. 2011 Sep;25(5):487-96. doi: 10.1111/j.1365-3016.2011.01215.x. Epub 2011 Jul 21. Paediatr Perinat Epidemiol. 2011. PMID: 21819430
-
Periconceptional use of weight loss products including ephedra and the association with birth defects.Birth Defects Res A Clin Mol Teratol. 2008 Aug;82(8):553-62. doi: 10.1002/bdra.20472. Birth Defects Res A Clin Mol Teratol. 2008. PMID: 18553492
-
Assisted reproductive technology and major structural birth defects in the United States.Hum Reprod. 2009 Feb;24(2):360-6. doi: 10.1093/humrep/den387. Epub 2008 Nov 14. Hum Reprod. 2009. PMID: 19010807
-
Maternal occupational exposure and risk of specific birth defects.Occup Med (Lond). 2006 Dec;56(8):532-43. doi: 10.1093/occmed/kql115. Occup Med (Lond). 2006. PMID: 17151389 Review.
-
Influenza and congenital anomalies: a systematic review and meta-analysis.Hum Reprod. 2014 Apr;29(4):809-23. doi: 10.1093/humrep/det455. Epub 2013 Dec 22. Hum Reprod. 2014. PMID: 24365800 Review.
Cited by
-
Prenatal exposure to antibiotics and the risk of orofacial clefts: a protocol for a systematic review and meta-analysis.BMJ Open. 2024 Nov 19;14(11):e092019. doi: 10.1136/bmjopen-2024-092019. BMJ Open. 2024. PMID: 39566936 Free PMC article.
-
First Trimester Tetracycline Exposure and Risk of Major Congenital Malformations.JAMA Netw Open. 2024 Nov 4;7(11):e2445055. doi: 10.1001/jamanetworkopen.2024.45055. JAMA Netw Open. 2024. PMID: 39541116 Free PMC article.
-
The first review on prenatal drug exposure and ocular malformation occurrence.Front Pediatr. 2024 Sep 4;12:1379875. doi: 10.3389/fped.2024.1379875. eCollection 2024. Front Pediatr. 2024. PMID: 39296666 Free PMC article. Review.
-
Dolutegravir- Versus Efavirenz-Based Treatment in Pregnancy: Impact on Red Blood Cell Folate Concentrations in Pregnant Women and Their Infants.J Infect Dis. 2024 Nov 15;230(5):1224-1234. doi: 10.1093/infdis/jiae308. J Infect Dis. 2024. PMID: 38877762 Free PMC article. Clinical Trial.
-
Real-world data are not always big data: the case for primary data collection on medication use in pregnancy in the context of birth defects research.Am J Epidemiol. 2024 Sep 3;193(9):1211-1214. doi: 10.1093/aje/kwae060. Am J Epidemiol. 2024. PMID: 38751306
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
